{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:15:14Z","timestamp":1791512114940,"version":"4.3.4"},"reference-count":118,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["5F31NS135955-02"],"award-info":[{"award-number":["5F31NS135955-02"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027043","name":"Milken Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012643","name":"Edward Mallinckrodt Jr Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000971","name":"ALS Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cell Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tcb.2025.11.003","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T13:26:37Z","timestamp":1765027597000},"page":"778-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Revisiting oligodendrocytes in amyotrophic lateral sclerosis using human multicellular stem cell models"],"prefix":"10.1016","volume":"36","author":[{"given":"Sabra","family":"Mouhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Pio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9320-6507","authenticated-orcid":false,"given":"Jimena","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcb.2025.11.003_bb0005","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tcb.2025.11.003_bb0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41576-023-00592-y","article-title":"Amyotrophic lateral sclerosis: translating genetic discoveries into therapies","volume":"24","author":"Ak\u00e7imen","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tcb.2025.11.003_bb0015","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.tcb.2025.11.003_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3121","article-title":"Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41582-020-00434-z","article-title":"Improving clinical trial outcomes in amyotrophic lateral sclerosis","volume":"17","author":"Kiernan","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fncel.2016.00119","article-title":"\u201cAstrocytes in oligodendrocyte lineage development and white matter pathology\u201d","volume":"10","author":"Li","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2021.12.008","article-title":"Human stem cell models of neurodegeneration: from basic science of amyotrophic lateral sclerosis to clinical translation","volume":"29","author":"Giacomelli","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-20892-3","article-title":"Single-cell transcriptomic reveals molecular diversity and developmental heterogeneity of human stem cell-derived oligodendrocyte lineage cells","volume":"12","author":"Chamling","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.11.003_bb0045","doi-asserted-by":"crossref","first-page":"R511","DOI":"10.1016\/S0960-9822(07)00334-X","article-title":"5000-year-old myelin: uniquely intact in molecular configuration and fine structure","volume":"8","author":"Hess","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41593-018-0120-6","article-title":"Lifelong cortical myelin plasticity and age-related degeneration in the live mammalian brain","volume":"21","author":"Hill","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0055","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1073\/pnas.1113540109","article-title":"Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination","volume":"109","author":"Chong","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0301-0082(93)90015-K","article-title":"Myelinated nerve fibres in the CNS","volume":"40","author":"Hildebrand","year":"1993","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105788","article-title":"The iron maiden: oligodendroglial metabolic dysfunction in multiple sclerosis and mitochondrial signaling","volume":"164","author":"Emamnejad","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tcb.2025.11.003_bb0070","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nbt.1972","article-title":"CD140a identifies a population of highly myelinogenic, migration-competent, and efficiently engrafting human oligodendrocyte progenitor cells","volume":"29","author":"Sim","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-neuro-112723-025806","article-title":"\u201cThe many lives of an oligodendrocyte precursor cell\u201d","volume":"48","author":"Buchanan","year":"2025","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.779125","article-title":"Neuron to oligodendrocyte precursor cell synapses: protagonists in oligodendrocyte development and myelination, and targets for therapeutics","volume":"15","author":"Moura","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn6204","article-title":"Oligodendrocyte precursors guide interneuron migration by unidirectional contact repulsion","volume":"376","author":"Lepiemme","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tcb.2025.11.003_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1101\/gad.344218.120","article-title":"Cell of all trades: oligodendrocyte precursor cells in synaptic, vascular, and immune function","volume":"35","author":"Akay","year":"2021","journal-title":"Genes Dev."},{"key":"10.1016\/j.tcb.2025.11.003_bb0095","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00424-023-02837-5","article-title":"Oligodendrocyte precursor cells: the multitaskers in the brain","volume":"475","author":"Fang","year":"2023","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.stem.2010.07.014","article-title":"Origin of new glial cells in intact and injured adult spinal cord","volume":"7","author":"Barnab\u00e9-Heider","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12915-022-01325-z","article-title":"Spatial and temporal heterogeneity in the lineage progression of fine oligodendrocyte subtypes","volume":"20","author":"Hilscher","year":"2022","journal-title":"BMC Biol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41593-019-0581-2","article-title":"\u201cFunctionally distinct subgroups of oligodendrocyte precursor cells integrate neural activity and execute myelin formation\u201d","volume":"23","author":"Marisca","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0115","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.nbd.2011.03.003","article-title":"Cx32 and Cx47 mediate oligodendrocyte:astrocyte and oligodendrocyte: oligodendrocyte gap junction coupling","volume":"42","author":"Wasseff","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tcb.2025.11.003_bb0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(88)90392-3","article-title":"A role for platelet-derived growth factor in normal gliogenesis in the central nervous system","volume":"53","author":"Richardson","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.mcn.2004.04.004","article-title":"Oligodendrocyte maturation is inhibited by bone morphogenetic protein","volume":"26","author":"See","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/cells13020184","article-title":"Microglia-derived insulin-like growth factor 1 is critical for neurodevelopment","volume":"13","author":"Rusin","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.tcb.2025.11.003_bb0135","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI26836","article-title":"Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis","volume":"116","author":"Butovsky","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tcb.2025.11.003_bb0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.tcb.2025.11.003_bb0145","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1093\/brain\/awac307","article-title":"Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?","volume":"145","author":"Tepav\u010devi\u0107","year":"2022","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0150","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1038\/s41467-019-11638-3","article-title":"Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination","volume":"10","author":"Kirby","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.11.003_bb0155","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/s41591-018-0236-y","article-title":"Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis","volume":"24","author":"Falc\u00e3o","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.tcb.2025.11.003_bb0160","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241188","article-title":"Oligodendrocyte-derived IL-33 regulates self-reactive CD8+ T cells in CNS autoimmunity","volume":"222","author":"Fonta","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tcb.2025.11.003_bb0165","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s11064-017-2343-4","article-title":"The role of the oligodendrocyte lineage in acute brain trauma","volume":"42","author":"Scheller","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tcb.2025.11.003_bb0170","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1038\/s41467-020-19453-x","article-title":"Distinct oligodendrocyte populations have spatial preference and different responses to spinal cord injury","volume":"11","author":"Floriddia","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.11.003_bb0175","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1007\/s00018-021-03802-0","article-title":"Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders","volume":"78","author":"Spaas","year":"2021","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.tcb.2025.11.003_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.1083159","article-title":"Functions and dysfunctions of oligodendrocytes in neurodegenerative diseases","volume":"16","author":"Han","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0185","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-007-0206-9","article-title":"TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation","volume":"113","author":"Tan","year":"2007","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.tcb.2025.11.003_bb0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.jnen.0000248554.45456.58","article-title":"TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions","volume":"66","author":"Neumann","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ana.26288","article-title":"Human oligodendrocyte myelination potential; relation to age and differentiation","volume":"91","author":"Luo","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0200","doi-asserted-by":"crossref","first-page":"18309","DOI":"10.1038\/s41598-025-03089-2","article-title":"MHC class I and II expression and induction in oligodendrocytes varies with age","volume":"15","author":"Catenacci","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tcb.2025.11.003_bb0205","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.20101880","article-title":"Tissue plasminogen activator prevents white matter damage following stroke","volume":"208","author":"Correa","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tcb.2025.11.003_bb0210","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","article-title":"A shared disease-associated oligodendrocyte signature among multiple CNS pathologies","volume":"25","author":"Kenigsbuch","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111189","article-title":"Disease-associated oligodendrocyte responses across neurodegenerative diseases","volume":"40","author":"Pandey","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tcb.2025.11.003_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12980","article-title":"Regulation of CNS pathology by Serpina3n\/SERPINA3: the knowns and the puzzles","volume":"50","author":"Zhu","year":"2024","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.11.003_bb0230","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1089\/neu.2010.1597","article-title":"Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-\u03b1","volume":"28","author":"Su","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.tcb.2025.11.003_bb0235","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1471-4159.2008.05405.x","article-title":"Glial connexins and gap junctions in CNS inflammation and disease","volume":"106","author":"Kielian","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tcb.2025.11.003_bb0240","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/glia.23980","article-title":"Activated microglia drive demyelination via CSF1R signaling","volume":"69","author":"Marzan","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.tcb.2025.11.003_bb0245","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/glia.23721","article-title":"NG2 glia are required for maintaining microglia homeostatic state","volume":"68","author":"Liu","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.tcb.2025.11.003_bb0250","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","article-title":"Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice","volume":"302","author":"Clement","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.tcb.2025.11.003_bb0255","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1523\/JNEUROSCI.22-12-04825.2002","article-title":"Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease","volume":"22","author":"Lino","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0260","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.1123511","article-title":"Onset and progression in inherited ALS determined by motor neurons and microglia","volume":"312","author":"Boill\u00e9e","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tcb.2025.11.003_bb0265","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1073\/pnas.0802556105","article-title":"Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice","volume":"105","author":"Yamanaka","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tcb.2025.11.003_bb0270","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","article-title":"Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis","volume":"16","author":"Kang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0275","first-page":"236","article-title":"Myelin composition of spinal cord in a model of amyotrophic lateral sclerosis (ALS) in SOD1G93A transgenic rats","volume":"45","author":"Niebroj-Dobosz","year":"2007","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0280","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/glia.20604","article-title":"Adult glial precursor proliferation in mutant SOD1G93A mice","volume":"56","author":"Magnus","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.tcb.2025.11.003_bb0285","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuron.2010.09.009","article-title":"NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration","volume":"68","author":"Kang","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.tcb.2025.11.003_bb0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature11314","article-title":"Oligodendroglia metabolically support axons and contribute to neurodegeneration","volume":"487","author":"Lee","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.11.003_bb0295","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00401-017-1687-9","article-title":"Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis","volume":"133","author":"Scekic-Zahirovic","year":"2017","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.tcb.2025.11.003_bb0300","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tcb.2025.11.003_bb0305","doi-asserted-by":"crossref","first-page":"E10941","DOI":"10.1073\/pnas.1809821115","article-title":"Cell-autonomous requirement of TDP-43, an ALS\/FTD signature protein, for oligodendrocyte survival and myelination","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tcb.2025.11.003_bb0310","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75230","article-title":"Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43","volume":"11","author":"Heo","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.tcb.2025.11.003_bb0315","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40478-024-01893-x","article-title":"ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice","volume":"12","author":"Horiuchi","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tcb.2025.11.003_bb0320","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201910213","article-title":"TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination","volume":"220","author":"Ho","year":"2021","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0325","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1038\/s41467-025-58634-4","article-title":"Correction of dysregulated lipid metabolism normalizes gene expression in oligodendrocytes and prolongs lifespan in female poly-GA C9orf72 mice","volume":"16","author":"Rezaei","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.11.003_bb0330","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/brain\/aws339","article-title":"Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis","volume":"136","author":"Philips","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.tcb.2025.11.003_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41593-022-01205-3","article-title":"Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes","volume":"26","author":"Humphrey","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.705306","article-title":"Dysregulation in subcellular localization of myelin basic protein mRNA does not result in altered myelination in amyotrophic lateral sclerosis","volume":"15","author":"Barton","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0345","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/path.5455","article-title":"Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis","volume":"251","author":"Lorente Pons","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12060554","article-title":"Lipid metabolism is dysregulated in the motor cortex white matter in amyotrophic lateral sclerosis","volume":"12","author":"Sadler","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.tcb.2025.11.003_bb0355","article-title":"pTDP-43 levels correlate with cell type\u2013specific molecular alterations in the prefrontal cortex of C9orf72 ALS\/FTD patients","volume":"122","author":"Wang","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0360","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00401-011-0805-3","article-title":"Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis","volume":"121","author":"Forsberg","year":"2011","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.tcb.2025.11.003_bb0365","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-014-1299-6","article-title":"TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord","volume":"128","author":"Brettschneider","year":"2014","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.tcb.2025.11.003_bb0370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40478-015-0226-y","article-title":"Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways","volume":"3","author":"Fatima","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tcb.2025.11.003_bb0375","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.cell.2024.02.031","article-title":"Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD","volume":"187","author":"Pineda","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/cells12111523","article-title":"Current state and future directions in the therapy of ALS","volume":"12","author":"Tzeplaeff","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.tcb.2025.11.003_bb0385","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S1740925X09990317","article-title":"Fate determination of adult human glial progenitor cells","volume":"5","author":"Sim","year":"2009","journal-title":"Neuron Glia Biol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0390","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.expneurol.2016.03.017","article-title":"Targeting human oligodendrocyte progenitors for myelin repair","volume":"283","author":"Dietz","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0395","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.stem.2008.03.020","article-title":"Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse","volume":"2","author":"Windrem","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0400","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cell.2014.10.011","article-title":"Dynamics of oligodendrocyte generation and myelination in the human brain","volume":"159","author":"Yeung","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0405","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nn1394","article-title":"Prefrontal white matter volume is disproportionately larger in humans than in other primates","volume":"8","author":"Schoenemann","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2013.00003","article-title":"Different scaling of white matter volume, cortical connectivity, and gyrification across rodent and primate brains","volume":"7","author":"Ventura-Antunes","year":"2013","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.tcb.2025.11.003_bb0415","doi-asserted-by":"crossref","first-page":"24334","DOI":"10.1073\/pnas.1907982116","article-title":"Accelerated evolution of oligodendrocytes in the human brain","volume":"116","author":"Berto","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2025.1566155","article-title":"Genetic association between gene expression profiles in oligodendrocyte precursor cells and psychiatric disorders","volume":"16","author":"Kondo","year":"2025","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.tcb.2025.11.003_bb0425","first-page":"1","article-title":"Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tcb.2025.11.003_bb0430","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/glia.23733","article-title":"Stem cell derived oligodendrocytes to study myelin diseases","volume":"68","author":"Chanoumidou","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.tcb.2025.11.003_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027925","article-title":"Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination","volume":"6","author":"Pouya","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tcb.2025.11.003_bb0440","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nprot.2015.075","article-title":"Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells","volume":"10","author":"Douvaras","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tcb.2025.11.003_bb0445","doi-asserted-by":"crossref","first-page":"E2243","DOI":"10.1073\/pnas.1614412114","article-title":"Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors","volume":"114","author":"Ehrlich","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0450","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.stemcr.2021.03.001","article-title":"One-step reprogramming of human fibroblasts into oligodendrocyte-like cells by SOX10, OLIG2, and NKX6.2","volume":"16","author":"Chanoumidou","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tcb.2025.11.003_bb0455","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.stemcr.2017.12.014","article-title":"SOX10 single transcription factor-based fast and efficient generation of oligodendrocytes from human pluripotent stem cells","volume":"10","author":"Garc\u00eda-Le\u00f3n","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tcb.2025.11.003_bb0460","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.stemcr.2014.03.007","article-title":"Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes","volume":"2","author":"Numasawa-Kuroiwa","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tcb.2025.11.003_bb0465","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.stem.2024.08.002","article-title":"Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis","volume":"31","author":"Clayton","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0470","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.stem.2018.07.009","article-title":"GFAP mutations in astrocytes impair oligodendrocyte progenitor proliferation and myelination in an hiPSC model of Alexander disease","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0475","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-025-00838-9","article-title":"Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis","volume":"20","author":"Trautwig","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tcb.2025.11.003_bb0480","doi-asserted-by":"crossref","first-page":"E6496","DOI":"10.1073\/pnas.1607496113","article-title":"Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism","volume":"113","author":"Ferraiuolo","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0485","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nprot.2013.039","article-title":"A rapid and reproducible assay for modeling myelination by oligodendrocytes using engineered nanofibers","volume":"8","author":"Lee","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tcb.2025.11.003_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.748849","article-title":"Novel in vitro experimental approaches to study myelination and remyelination in the central nervous system","volume":"15","author":"Marangon","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0495","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41592-018-0081-4","article-title":"Induction of myelinating oligodendrocytes in human cortical spheroids","volume":"15","author":"Madhavan","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tcb.2025.11.003_bb0500","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41593-018-0316-9","article-title":"Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures","volume":"22","author":"Marton","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tcb.2025.11.003_bb0505","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.devcel.2021.04.006","article-title":"iPSC-derived myelinoids to study myelin biology of humans","volume":"56","author":"James","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0510","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.stemcr.2019.04.011","article-title":"Pluripotent stem cell-derived cerebral organoids reveal human oligodendrogenesis with dorsal and ventral origins","volume":"12","author":"Kim","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tcb.2025.11.003_bb0515","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tcb.2025.11.003_bb0520","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00401-023-02666-x","article-title":"Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs","volume":"147","author":"Zhu","year":"2024","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.tcb.2025.11.003_bb0525","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/stem.2273","article-title":"Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes","volume":"34","author":"Livesey","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.tcb.2025.11.003_bb0530","article-title":"Transactive response DNA-binding protein-43 proteinopathy in oligodendrocytes revealed using an induced pluripotent stem cell model","volume":"3","author":"Barton","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.tcb.2025.11.003_bb0535","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature22403","article-title":"Common genetic variation drives molecular heterogeneity in human iPSCs","volume":"546","author":"Kilpinen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2025.11.003_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115402","article-title":"ALS molecular subtypes are a combination of cellular and pathological features learned by deep multiomics classifiers","volume":"44","author":"O\u2019Neill","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.tcb.2025.11.003_bb0545","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1038\/s41467-023-41033-y","article-title":"Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2025.11.003_bb2005","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.immuni.2025.02.024","article-title":"Single cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 in ALS pathogenesis","volume":"58","author":"Zelic","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.tcb.2025.11.003_bb0550","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.stem.2021.08.015","article-title":"Human microglia states are conserved across experimental models and regulate neural stem cell responses in chimeric organoids","volume":"28","author":"Popova","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0555","article-title":"Engineered 3D immuno-glial-neurovascular human mibrain model","author":"Stanton","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.tcb.2025.11.003_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2025.102535","article-title":"Telmisartan is neuroprotective in a hiPSC-derived spinal microtissue model for C9orf72 ALS via inhibition of neuroinflammation","volume":"20","author":"Sonustun","year":"2025","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tcb.2025.11.003_bb0565","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp7047","article-title":"Human myelinated brain organoids with integrated microglia as a model for myelin repair and remyelinating therapies","volume":"17","author":"Lange","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tcb.2025.11.003_bb0570","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.cell.2020.11.017","article-title":"Generation of functional human 3D cortico-motor assembloids","volume":"183","author":"Andersen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2025.11.003_bb0575","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.isci.2019.03.012","article-title":"A human induced pluripotent stem cell-derived tissue model of a cerebral tract connecting two cortical regions","volume":"14","author":"Kirihara","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.tcb.2025.11.003_bb0580","series-title":"A phase 1\/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury","author":"Fessler","year":"2022"},{"key":"10.1016\/j.tcb.2025.11.003_bb0585","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-022-01956-3","article-title":"Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial","volume":"28","author":"Baloh","year":"2022","journal-title":"Nat. Med."}],"container-title":["Trends in Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096289242500251X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096289242500251X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:36:04Z","timestamp":1789504564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096289242500251X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":118,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S096289242500251X"],"URL":"https:\/\/doi.org\/10.1016\/j.tcb.2025.11.003","relation":{},"ISSN":["0962-8924"],"issn-type":[{"value":"0962-8924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting oligodendrocytes in amyotrophic lateral sclerosis using human multicellular stem cell models","name":"articletitle","label":"Article Title"},{"value":"Trends in Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcb.2025.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}